Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments that have reshaped the obesity

(NewsNation) — An estimated 15.5 million U.S. adults have used injectable diabetes medicines like Ozempic and Wegovy to lose weight, according to a Gallup poll released Tuesday. The nationwide survey found 6% of Americans say they have tried the drugs ...

"Food noise" is the buzz in the battle against obesity. GLP1 injectables don't just decrease appetite, but also quiet "food noise," the preoccupation with food that occurs in obesity.

A key to the pill's success will be attracting cash-paying consumers who cannot obtain insurance coverage, a stark shift from the dominant business model.

Bags of IV drugs distributed nationwide are being recalled for being mislabeled as a lesser-dose than what the drugs actually are, increasing the risk for overdosing and even death, according to the FDA. ICU Medical Inc. is recalling one lot of potassium ...

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and carbidopa tablets several times a day. These frequent doses ...

Mark Cuban’s latest move to disrupt the pharmaceutical supply chain is expanding — this time, tackling the injectable drug market through a new partnership with distributor Morris & Dickson. His company, Mark Cuban Cost Plus Drug Co., is partnering ...

Long-acting injectables (LAIs) are sustained drug delivery systems specifically designed so that medication is released into the body gradually over an extended period of time. Image Credit: Powder Systems The concept of extending the release of active ...